Accelerating Clinical Trials with Location

Despite how critical clinical trials are for medical innovation, they face key challenges that can delay or even derail them entirely—patient recruitment, site selection, retention, and operational inefficiencies.

Geospatial AI is reshaping clinical trials by combining location-based data with AI to analyze and visualize geographic patterns and trends. By leveraging geospatial AI, clinical trial researchers can harness insights into patient demographics, disease prevalence, and healthcare infrastructure to improve trial efficiency, reduce costs, and accelerate timelines.

‍

Benefits of Using Geospatial AI in Clinical Trials

Researchers incorporating geospatial AI into clinical trial design and delivery can expect several key benefits. First, it accelerates trial timelines and reduces costs by optimizing site selection, taking into account factors such as the geographic distribution of diseases. Second, it reduces costly recruitment delays and improves operational efficiency. Third, geospatial AI promotes greater diversity in clinical trials by targeting underrepresented populations, enhancing the generalizability of trial results. Lastly, real-time monitoring can flag locations where participant enrollment is low or retention rates are poor.

‍‍

1. Optimize Trial Site Selection

Geospatial AI accelerates trial timelines by optimizing site selection, taking into account factors such as the geographic distribution of diseases, helping trials complete faster, and reducing costs:

• Disease Mapping: Identify geographic regions with a high prevalence of the target condition to ensure adequate patient pools.
• Infrastructure Analysis: Evaluate proximity to hospitals, transportation networks, and other healthcare facilities to support trial logistics.
• Historical Performance: Analyze past trial site success rates to predict performance at new sites.

‍

2. Enhance Patient Recruitment and Retention

Patient recruitment is a key challenge for clinical trials–approximately 80% of trials are delayed, or even close, because of recruitment issues. These delays can result in lost revenue of as much as $8 million per day for companies developing drugs. Geospatial AI can:

• Identify Eligible Populations: Analyze electronic health records and demographic data to find eligible patients near trial sites.
• Target Outreach Campaigns: Use geospatial insights to focus recruitment efforts in high-potential areas, optimizing marketing budgets and maximizing reach.

‍

3. Ensure Diversity and Equity

Poor diversity in clinical trials undermines the generalizability of results, a challenge that can be addressed by:

• Identifying Underserved Communities: Mapping underserved or underrepresented communities affected by the target disease.
• Ensuring Accessibility: Making sure trial sites are accessible to diverse populations.
• Tackling Barriers: Proactively addressing barriers to participation, such as transportation or language.

For example, a trial targeting diabetes could identify high-prevalence areas with minority populations historically underrepresented in clinical research.

‍

4. Real-Time Monitoring and Risk Management

Geospatial AI enables real-time monitoring of clinical trials by geographically analyzing patient enrollment, retention rates, and adverse events.

• Risk Hotspot Identification: Highlight geographic areas with higher dropout rates or adverse events, enabling targeted interventions.
• Supply Chain Optimization: Map drug delivery routes and ensure timely supply to trial sites.

‍

Are You Ready to Incorporate Geospatial AI into Your Clinical Trials?

Whether you're a sponsor, researcher, or CRO, investing in geospatial AI is essential to stay competitive. Its ability to analyze complex data, predict outcomes, and improve decision-making makes trials faster, more cost-effective, and inclusive.

‍

If you're weighing geospatial AI for an upcoming trial and want to compare notes, email me at mike@variatehealth.com.